 | • レポートコード：QY20ST-05720 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の組換えベクターワクチン市場について種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他）、用途別（大人用、子供用）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・組換えベクターワクチン市場の概要 ・世界の主要地域別組換えベクターワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の組換えベクターワクチン市場規模2015-2026：種類別（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他） ・世界の組換えベクターワクチン市場規模2015-2026：用途別（大人用、子供用） ・組換えベクターワクチンの北米市場規模2015-2020 ・組換えベクターワクチンのヨーロッパ市場規模2015-2020 ・組換えベクターワクチンの中国市場規模2015-2020 ・組換えベクターワクチンの日本市場規模2015-2020 ・組換えベクターワクチンの東南アジア市場規模2015-2020 ・組換えベクターワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・組換えベクターワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・組換えベクターワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Recombinant Vector Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Recombinant Vector Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier.
In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells. Recombinant vector vaccines closely mimic a natural infection and therefore do a good job of stimulating the immune system.
Attenuated bacteria also can be used as vectors. In this case, the inserted genetic material causes the bacteria to display the antigens of other microbes on its surface. In effect, the harmless bacterium mimics a harmful microbe, provoking an immune response.
Researchers are working on both bacteria-l and viral-based recombinant vector vaccines for HIV, rabies, and measles.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Vector Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Vector Vaccines industry.
Based on our recent survey, we have several different scenarios about the Recombinant Vector Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Vector Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Recombinant Vector Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Recombinant Vector Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Recombinant Vector Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Recombinant Vector Vaccines market. The report also includes nautical information, where it shows Recombinant Vector Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Recombinant Vector Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Recombinant Vector Vaccines market.
Geographical Analysis:
Based on region, the global Recombinant Vector Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Recombinant Vector Vaccines market are
SANOFI PASTEUR S.A.
Novartis
GSK
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
Segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others
Segment by Application
For Adult
For Child
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Recombinant Vector Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Recombinant Vector Vaccines market.
• The market share of the global Recombinant Vector Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Recombinant Vector Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Recombinant Vector Vaccines market.
1 Recombinant Vector Vaccines Market Overview
1.1 Recombinant Vector Vaccines Product Scope
1.2 Recombinant Vector Vaccines Segment by Type
1.2.1 Global Recombinant Vector Vaccines Sales by Type (2020-2026)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Recombinant Vector Vaccines Segment by Application
1.3.1 Global Recombinant Vector Vaccines Sales Comparison by Application (2020-2026)
1.3.2 For Adult
1.3.3 For Child
1.4 Recombinant Vector Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Vector Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Vector Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Vector Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Recombinant Vector Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Recombinant Vector Vaccines Industry
1.5.1.1 Recombinant Vector Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Recombinant Vector Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Recombinant Vector Vaccines Players to Combat Covid-19 Impact
2 Recombinant Vector Vaccines Estimate and Forecast by Region
2.1 Global Recombinant Vector Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Vector Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Vector Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Vector Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Vector Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Vector Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Vector Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Vector Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Vector Vaccines Estimates and Projections (2015-2026)
2.4.3 China Recombinant Vector Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Vector Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Vector Vaccines Estimates and Projections (2015-2026)
2.4.6 India Recombinant Vector Vaccines Estimates and Projections (2015-2026)
3 Global Recombinant Vector Vaccines Competition Landscape by Players
3.1 Global Top Recombinant Vector Vaccines Players by Sales (2015-2020)
3.2 Global Top Recombinant Vector Vaccines Players by Revenue (2015-2020)
3.3 Global Recombinant Vector Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Vector Vaccines as of 2019)
3.4 Global Recombinant Vector Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Vector Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Vector Vaccines Players (Opinion Leaders)
4 Global Recombinant Vector Vaccines Market Size by Type
4.1 Global Recombinant Vector Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Vector Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Vector Vaccines Price by Type (2014-2020)
4.2 Global Recombinant Vector Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Vector Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Vector Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Vector Vaccines Price Forecast by Type (2021-2026)
5 Global Recombinant Vector Vaccines Market Size by Application
5.1 Global Recombinant Vector Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Vector Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Vector Vaccines Price by Application (2015-2020)
5.2 Global Recombinant Vector Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Vector Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Vector Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Vector Vaccines Price Forecast by Application (2021-2026)
3 North America Recombinant Vector Vaccines Market Facts & Figures
3.2 North America Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
4 Europe Recombinant Vector Vaccines Market Facts & Figures
4.2 Europe Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
5 China Recombinant Vector Vaccines Market Facts & Figures
5.2 China Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
5.3 China Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
5.4 China Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
6 Japan Recombinant Vector Vaccines Market Facts & Figures
6.2 Japan Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Recombinant Vector Vaccines Market Facts & Figures
7.2 Southeast Asia Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
8 India Recombinant Vector Vaccines Market Facts & Figures
8.2 India Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
8.3 India Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
8.4 India Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Recombinant Vector Vaccines Business
12.1 SANOFI PASTEUR S.A.
12.1.1 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Corporation Information
12.1.2 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Business Overview and Total Revenue
12.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Products Offered
12.1.5 SANOFI PASTEUR S.A. Recent Development
12.2 Novartis
12.2.1 Novartis Recombinant Vector Vaccines Corporation Information
12.2.2 Novartis Recombinant Vector Vaccines Business Overview and Total Revenue
12.2.3 Novartis Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Recombinant Vector Vaccines Products Offered
12.2.5 Novartis Recent Development
12.3 GSK
12.3.1 GSK Recombinant Vector Vaccines Corporation Information
12.3.2 GSK Recombinant Vector Vaccines Business Overview and Total Revenue
12.3.3 GSK Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Recombinant Vector Vaccines Products Offered
12.3.5 GSK Recent Development
12.4 CNBG
12.4.1 CNBG Recombinant Vector Vaccines Corporation Information
12.4.2 CNBG Recombinant Vector Vaccines Business Overview and Total Revenue
12.4.3 CNBG Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 CNBG Recombinant Vector Vaccines Products Offered
12.4.5 CNBG Recent Development
12.5 ChengDa Bio
12.5.1 ChengDa Bio Recombinant Vector Vaccines Corporation Information
12.5.2 ChengDa Bio Recombinant Vector Vaccines Business Overview and Total Revenue
12.5.3 ChengDa Bio Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 ChengDa Bio Recombinant Vector Vaccines Products Offered
12.5.5 ChengDa Bio Recent Development
12.6 Changsheng Life
12.6.1 Changsheng Life Recombinant Vector Vaccines Corporation Information
12.6.2 Changsheng Life Recombinant Vector Vaccines Business Overview and Total Revenue
12.6.3 Changsheng Life Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Changsheng Life Recombinant Vector Vaccines Products Offered
12.6.5 Changsheng Life Recent Development
12.7 Zhifei
12.7.1 Zhifei Recombinant Vector Vaccines Corporation Information
12.7.2 Zhifei Recombinant Vector Vaccines Business Overview and Total Revenue
12.7.3 Zhifei Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zhifei Recombinant Vector Vaccines Products Offered
12.7.5 Zhifei Recent Development
12.8 SINOVAC BIOTECH
12.8.1 SINOVAC BIOTECH Recombinant Vector Vaccines Corporation Information
12.8.2 SINOVAC BIOTECH Recombinant Vector Vaccines Business Overview and Total Revenue
12.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 SINOVAC BIOTECH Recombinant Vector Vaccines Products Offered
12.8.5 SINOVAC BIOTECH Recent Development
12.9 NuoCheng Bio
12.9.1 NuoCheng Bio Recombinant Vector Vaccines Corporation Information
12.9.2 NuoCheng Bio Recombinant Vector Vaccines Business Overview and Total Revenue
12.9.3 NuoCheng Bio Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 NuoCheng Bio Recombinant Vector Vaccines Products Offered
12.9.5 NuoCheng Bio Recent Development
12.10 Hualan Bio
12.10.1 Hualan Bio Recombinant Vector Vaccines Corporation Information
12.10.2 Hualan Bio Recombinant Vector Vaccines Business Overview and Total Revenue
12.10.3 Hualan Bio Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hualan Bio Recombinant Vector Vaccines Products Offered
12.10.5 Hualan Bio Recent Development
12.11 Kangtai
12.11.1 Kangtai Recombinant Vector Vaccines Corporation Information
12.11.2 Kangtai Recombinant Vector Vaccines Business Overview and Total Revenue
12.11.3 Kangtai Recombinant Vector Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Kangtai Recombinant Vector Vaccines Products Offered
12.11.5 Kangtai Recent Development
13 Recombinant Vector Vaccines Manufacturing Cost Analysis
13.1 Recombinant Vector Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Vector Vaccines
13.4 Recombinant Vector Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Vector Vaccines Distributors List
14.3 Recombinant Vector Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Recombinant Vector Vaccines Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Recombinant Vector Vaccines Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Recombinant Vector Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Recombinant Vector Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Recombinant Vector Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Recombinant Vector Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Recombinant Vector Vaccines Sales (K Doses) by Region (2015-2020)
Table 10. Global Recombinant Vector Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Recombinant Vector Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Recombinant Vector Vaccines Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Recombinant Vector Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Recombinant Vector Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Recombinant Vector Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Recombinant Vector Vaccines (K Doses) of Key Companies (2015-2020)
Table 18. Global Recombinant Vector Vaccines Sales Share by Company (2015-2020)
Table 19. Global Recombinant Vector Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Recombinant Vector Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Recombinant Vector Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Vector Vaccines as of 2019)
Table 22. Global Recombinant Vector Vaccines Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Recombinant Vector Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Recombinant Vector Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Recombinant Vector Vaccines Players
Table 27. Global Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 28. Global Recombinant Vector Vaccines Sales Share by Type (2015-2020)
Table 29. Global Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Recombinant Vector Vaccines Price (K Doses) by Type (2015-2020)
Table 31. Global Recombinant Vector Vaccines Sales Share by Type (2021-2026)
Table 32. Global Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Recombinant Vector Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Recombinant Vector Vaccines Price (K Doses) by Type (2021-2026)
Table 35. Global Recombinant Vector Vaccines Sales (K Doses) by Application (2015-2020)
Table 36. Global Recombinant Vector Vaccines Sales Share by Application (2015-2020)
Table 37. Global Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Recombinant Vector Vaccines Price (K Doses) by Application (2015-2020)
Table 39. Global Recombinant Vector Vaccines Sales (K Doses) by Application (2021-2026)
Table 40. Global Recombinant Vector Vaccines Sales Share by Application (2021-2026)
Table 41. Global Recombinant Vector Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Recombinant Vector Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Recombinant Vector Vaccines Price (K Doses) by Application (2021-2026)
Table 44. United States Recombinant Vector Vaccines Sales (K Doses) by Company (2015-2020)
Table 45. United States Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 47. United States Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Recombinant Vector Vaccines Sales (K Doses) by Application (2015-2020)
Table 49. United States Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Recombinant Vector Vaccines Sales (K Doses) by Company (2015-2020)
Table 51. Europe Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 53. Europe Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Recombinant Vector Vaccines Sales (K Doses) by Application (2015-2020)
Table 55. Europe Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Recombinant Vector Vaccines Sales (K Doses) by Company (2015-2020)
Table 57. China Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 59. China Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Recombinant Vector Vaccines Sales (K Doses) by Application (2015-2020)
Table 61. China Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Recombinant Vector Vaccines Sales (K Doses) by Company (2015-2020)
Table 63. Japan Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 65. Japan Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Recombinant Vector Vaccines Sales (K Doses) by Application (2015-2020)
Table 67. Japan Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Recombinant Vector Vaccines Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Recombinant Vector Vaccines Sales (K Doses) by Company (2015-2020)
Table 75. India Recombinant Vector Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Recombinant Vector Vaccines Sales (K Doses) by Type (2015-2020)
Table 77. India Recombinant Vector Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Recombinant Vector Vaccines Sales (K Doses) by Application (2015-2020)
Table 79. India Recombinant Vector Vaccines Sales Market Share by Application (2015-2020)
Table 80. SANOFI PASTEUR S.A. Corporation Information
Table 81. SANOFI PASTEUR S.A. Description and Business Overview
Table 82. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product
Table 84. SANOFI PASTEUR S.A. Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Novartis Recombinant Vector Vaccines Product
Table 89. Novartis Recent Development
Table 90. GSK Corporation Information
Table 91. GSK Description and Business Overview
Table 92. GSK Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. GSK Recombinant Vector Vaccines Product
Table 94. GSK Recent Development
Table 95. CNBG Corporation Information
Table 96. CNBG Description and Business Overview
Table 97. CNBG Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. CNBG Recombinant Vector Vaccines Product
Table 99. CNBG Recent Development
Table 100. ChengDa Bio Corporation Information
Table 101. ChengDa Bio Description and Business Overview
Table 102. ChengDa Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. ChengDa Bio Recombinant Vector Vaccines Product
Table 104. ChengDa Bio Recent Development
Table 105. Changsheng Life Corporation Information
Table 106. Changsheng Life Description and Business Overview
Table 107. Changsheng Life Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Changsheng Life Recombinant Vector Vaccines Product
Table 109. Changsheng Life Recent Development
Table 110. Zhifei Corporation Information
Table 111. Zhifei Description and Business Overview
Table 112. Zhifei Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Zhifei Recombinant Vector Vaccines Product
Table 114. Zhifei Recent Development
Table 115. SINOVAC BIOTECH Corporation Information
Table 116. SINOVAC BIOTECH Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. SINOVAC BIOTECH Description and Business Overview
Table 118. SINOVAC BIOTECH Recombinant Vector Vaccines Product
Table 119. SINOVAC BIOTECH Recent Development
Table 120. NuoCheng Bio Corporation Information
Table 121. NuoCheng Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. NuoCheng Bio Description and Business Overview
Table 123. NuoCheng Bio Recombinant Vector Vaccines Product
Table 124. NuoCheng Bio Recent Development
Table 125. Hualan Bio Corporation Information
Table 126. Hualan Bio Description and Business Overview
Table 127. Hualan Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Hualan Bio Recombinant Vector Vaccines Product
Table 129. Hualan Bio Recent Development
Table . Kangtai Corporation Information
Table . Kangtai Description and Business Overview
Table . Kangtai Recombinant Vector Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Kangtai Recombinant Vector Vaccines Product
Table . Kangtai Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Recombinant Vector Vaccines Distributors List
Table 138. Recombinant Vector Vaccines Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Vector Vaccines Product Picture
Figure 2. Global Recombinant Vector Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Vector Vaccines Market Share by Application in 2020 & 2026
Figure 6. For Adult Examples
Figure 7. For Child Examples
Figure 8. Global Recombinant Vector Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Recombinant Vector Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Recombinant Vector Vaccines Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Recombinant Vector Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Recombinant Vector Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Recombinant Vector Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Recombinant Vector Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Recombinant Vector Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Recombinant Vector Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Recombinant Vector Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Recombinant Vector Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Recombinant Vector Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Recombinant Vector Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Recombinant Vector Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Recombinant Vector Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Recombinant Vector Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Recombinant Vector Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Recombinant Vector Vaccines Players Market Share by Revenue in Recombinant Vector Vaccines 2015 & 2019
Figure 26. Recombinant Vector Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Recombinant Vector Vaccines Revenue Share by Type (2015-2020)
Figure 28. Global Recombinant Vector Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Recombinant Vector Vaccines Revenue Share by Application (2015-2020)
Figure 30. Global Recombinant Vector Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Recombinant Vector Vaccines Sales Market Share by Type in 2019
Figure 32. United States Recombinant Vector Vaccines Sales Market Share by Type in 2019
Figure 33. Europe Recombinant Vector Vaccines Sales Market Share by Company in 2019
Figure 34. Europe Recombinant Vector Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Recombinant Vector Vaccines Sales Market Share by Application in 2019
Figure 36. China Recombinant Vector Vaccines Sales Market Share by Company in 2019
Figure 37. China Recombinant Vector Vaccines Sales Market Share by Type in 2019
Figure 38. China Recombinant Vector Vaccines Sales Market Share by Application in 2019
Figure 39. Japan Recombinant Vector Vaccines Sales Market Share by Company in 2019
Figure 40. Japan Recombinant Vector Vaccines Sales Market Share by Type in 2019
Figure 41. Japan Recombinant Vector Vaccines Sales Market Share by Application in 2019
Figure 42. Southeast Asia Recombinant Vector Vaccines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Recombinant Vector Vaccines Sales Market Share by Type in 2019
Figure 44. Southeast Asia Recombinant Vector Vaccines Sales Market Share by Application in 2019
Figure 45. India Recombinant Vector Vaccines Sales Market Share by Company in 2019
Figure 46. India Recombinant Vector Vaccines Sales Market Share by Type in 2019
Figure 47. India Recombinant Vector Vaccines Sales Market Share by Application in 2019
Figure 48. SANOFI PASTEUR S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. ChengDa Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Changsheng Life Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Zhifei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. SINOVAC BIOTECH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. NuoCheng Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Kangtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Recombinant Vector Vaccines
Figure 61. Manufacturing Process Analysis of Recombinant Vector Vaccines
Figure 62. Recombinant Vector Vaccines Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
組換えハムスター卵巣細胞（CHO）B型肝炎ワクチンの世界市場レポート2020 Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chin…- 組換えトリプシンパウダーの世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Trypsin Powder Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides …
- 組換えトリプシン液体溶液の世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Trypsin Liquid Solution Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …
- 小児ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Childhood Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate…
- 犬用ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Dog Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data …